Bristol-Myers Squibb Co  

(Public, NYSE:BMY)   Watch this stock  
Find more results for BMY
60.92
-0.54 (-0.88%)
After Hours: 60.92 0.00 (0.00%)
Feb 27, 5:42PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 60.87 - 61.55
52 week 46.30 - 64.44
Open 61.24
Vol / Avg. 3.99M/5.82M
Mkt cap 102.14B
P/E 50.71
Div/yield 0.37/2.43
EPS 1.20
Shares 1.66B
Beta 0.33
Inst. own 72%
May 5, 2015
Bristol-Myers Squibb Co Annual Shareholders Meeting Add to calendar
Apr 27, 2015
Q1 2015 Bristol-Myers Squibb Co Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 3, 2015
Bristol-Myers Squibb Co at Cowen Health Care Conference - 9:20AM EST - Add to calendar
Feb 12, 2015
Bristol-Myers Squibb Co at Leerink Global Healthcare Conference
Jan 27, 2015
Q4 2014 Bristol-Myers Squibb Co Earnings Release
Jan 27, 2015
Q4 2014 Bristol-Myers Squibb Co Earnings Call
Jan 13, 2015
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 0.63% 12.78%
Operating margin -1.41% 11.41%
EBITD margin - 24.69%
Return on average assets 0.32% 5.61%
Return on average equity 0.35% 13.36%
Employees 25,000 -
CDP Score - 98 B

Address

345 PARK AVE
NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. It operates in BioPharmaceuticals. Its products are sold across the world, to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. It manufactures products in the United States, Puerto Rico and in six foreign countries. The Company�s pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes called biologics. Small molecule drugs are administered orally, for example, in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its revenues come from products in therapeutic classes: virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; metabolics; immunoscience; and cardiovascular.

Officers and directors

Charles A. Bancroft Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Louis S. Schmukler President - Global Manufacturing and Supply
Age: 58
Bio & Compensation  - Reuters
Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Francis M Cuss Executive Vice President, Chief Scientific Officer
Age: 59
Bio & Compensation  - Reuters
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 52
Bio & Compensation  - Reuters
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 53
Bio & Compensation  - Reuters
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ann Powell Judge Senior Vice President - Global Human Resources
Age: 47
Bio & Compensation  - Reuters
John E. Elicker Senior Vice President - Public Affairs and Investor Relations
Age: 54
Bio & Compensation  - Reuters
Brian Daniels M.D. Senior Vice President - Global Development & Medical Affairs, Research and Development
Age: 54
Bio & Compensation  - Reuters